Dr. Keown graduated in Medicine from the University of Manchester, and pursued postgraduate training in England, France, and Canada. He holds research Doctorates in both Medicine and in Science from the University of Manchester, and an MBA from Simon Fraser University in British Columbia. Dr. Keown’s research focuses particularly on the immune response in transplantation and autoimmune disease, and ranges from molecular genetics to healthcare economics.
Dr. Paul A. Keown is Professor of Medicine, Director of Immunology at the University of British Columbia, with appointments in Medicine, Pathology and Laboratory Medicine.
He has served as Executive Director of the British Columbia Transplant Society, Head of the UBC Division of Nephrology, president of the Canadian Transplant Society, Vice President and member of the Executive Committee of the Transplantation Society, and in numerous national and international scientific societies and professional organizations.
He was elected a Fellow of the Royal College of Physicians of Canada in 1977, the Royal College of Physicians of London in 1987, the American College of Physicians in 1994, the American Society of Nephrology and American Society of Angiology in 2008, and the Royal College of Pathologies and Royal Society of Chemistry in 2009.
Dr. Keown is the founder and C.E.O. of Syreon Corporation, a global research corporation specializing in the use of advanced information technologies for health sciences research.